|
Hospital Regional Carlos Haya (Málaga, Spain)
|
|
Graduate in Medicine (Granada University, 1989), Radiology medical training in Regional Carlos Haya Hospital ( Málaga, 1989-1992), Ph in Surgery and Medicine (Granada University, 1998). Experticse on neuroradiology, focusing on oncology and neurodegenerative disease. Head of the Radiology & Nuclear Medicine clinical department at Regional Carlos Haya hospital from 2010. |
Publications
-
Tumor Surface Regularity at MR Imaging Predicts Survival and Response to Surgery in Patients with Glioblastoma
Radiology 288(1), 218-225 (2018)
J. Pérez-Beteta, D. Molina, A. Fernández, B. Luque, E. Arregui, M. Calvo, J. M. Borrás, A. Fernández-Romero, B. Luque, B. Meléndez, A.R. de Lope, R. Moreno, L. Iglesias, J.A. Barcia, J. Martino, C. Velasquez, B. Asenjo, M. Benavides, I. Herruzo, A. Revert, E. Arana, V. M. Pérez-García
Projects
- Mathematical models for the digital transition in neuro-oncology: In-silico design of a clinical trial for glioblastoma.
Ministerio de Ciencia e Innovación (NextGenerationEU) (2023 - 2024)
Asenjo Martínez, Beatriz
Hospital Regional Carlos Haya (Málaga, Spain)
|
Graduate in Medicine (Granada University, 1989), Radiology medical training in Regional Carlos Haya Hospital ( Málaga, 1989-1992), Ph in Surgery and Medicine (Granada University, 1998). Experticse on neuroradiology, focusing on oncology and neurodegenerative disease. Head of the Radiology & Nuclear Medicine clinical department at Regional Carlos Haya hospital from 2010. |
Publications
- Tumor Surface Regularity at MR Imaging Predicts Survival and Response to Surgery in Patients with Glioblastoma
Radiology 288(1), 218-225 (2018)
J. Pérez-Beteta, D. Molina, A. Fernández, B. Luque, E. Arregui, M. Calvo, J. M. Borrás, A. Fernández-Romero, B. Luque, B. Meléndez, A.R. de Lope, R. Moreno, L. Iglesias, J.A. Barcia, J. Martino, C. Velasquez, B. Asenjo, M. Benavides, I. Herruzo, A. Revert, E. Arana, V. M. Pérez-García
Projects
- Mathematical models for the digital transition in neuro-oncology: In-silico design of a clinical trial for glioblastoma.
Ministerio de Ciencia e Innovación (NextGenerationEU) (2023 - 2024)
